Popular
Ready, Set, Act! Opportunities to Address Persistent Unmet Needs in Patients With HFrEF: A Case-Based Discussion
CME/CEReady, Set, Act! Opportunities to Address Persistent Unmet Needs in Patients With HFrEF: A Case-Based Discussion
Carolyn Lam, MD, PhD
Stephen J. Greene, MD
Hypopigmentation in Atopic Dermatitis Patients with Skin of Color
Dermatology Hub: Neuroimmune NetworkHypopigmentation in Atopic Dermatitis Patients with Skin of Color
Cheri Frey, MD
Brian P. McDonough, MD, FAAFP
Michael Moor, MD, PhD
Navigating Chronic Anticoagulation Reversal in Cardiothoracic Surgery
Heart MattersNavigating Chronic Anticoagulation Reversal in Cardiothoracic Surgery
Brian P. McDonough, MD, FAAFP
Ahmet Kilic, MD FACS
Stroke-Like Symptoms During Treatment: Safety First
MinuteCE®Stroke-Like Symptoms During Treatment: Safety First
Dani Cabral, MD
David Weisman, MD
Programs
Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients With Multiple Myeloma
MinuteCE®Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients With Multiple Myeloma
Natalie S. Callander, MD
Talking Through Benefits, Risks, and Patient Priorities
MinuteCE®Talking Through Benefits, Risks, and Patient Priorities
Dani Cabral, MD
David Weisman, MD
Case Consult: Implementing Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients
MinuteCE®Case Consult: Implementing Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients
Saad Z. Usmani, MD, MBA
Natalie S. Callander, MD
Case Consult: Implementing Anti-CD38–Based Frontline Regimens in Transplant-Ineligible Patients
MinuteCE®Case Consult: Implementing Anti-CD38–Based Frontline Regimens in Transplant-Ineligible Patients
Saad Z. Usmani, MD, MBA
Natalie S. Callander, MD
Dani Cabral, MD
David Weisman, MD
Disease Deep Dive: The Evolving Role of Nonsteroidal Topical Therapy for Atopic Dermatitis
Practical DermatologyDisease Deep Dive: The Evolving Role of Nonsteroidal Topical Therapy for Atopic Dermatitis
Walter Liszewski, MD
Adelaide Hebert, MD
Clinical Practice
APOC3 Inhibition in FCS and Severe Hypertriglyceridemia
CardiologyAPOC3 Inhibition in FCS and Severe Hypertriglyceridemia
Erik Stroes
Borderline Biomarkers: When a Blood Test Is Not Enough
MinuteCE®Borderline Biomarkers: When a Blood Test Is Not Enough
Dani Cabral, MD
David Weisman, MD
The Sequencing Puzzle: Integrating Oral SERDs and PROTACs into the mBC Treatment Landscape
MinuteCE®The Sequencing Puzzle: Integrating Oral SERDs and PROTACs into the mBC Treatment Landscape
Komal Jhaveri, MD, FACP
Virginia Kaklamani, MD, DSc
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
CME/CE Broadcast ReplayWhen “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
Dani Cabral, MD
David Weisman, MD
Dani Cabral, MD
David Weisman, MD
Doctors Lounge
Humanoids in Healthcare: Extending the Reach of Surgical Expertise
The ConvergenceHumanoids in Healthcare: Extending the Reach of Surgical Expertise
Brian P. McDonough, MD, FAAFP
Michael Yip, PhD
Brian P. McDonough, MD, FAAFP
Raja-Elie E. Abdulnour, MD
Jean-Claude Saghbini
Engaging Patients and Caregivers About Digital Therapeutics
Medical Industry FeatureEngaging Patients and Caregivers About Digital Therapeutics
Charles Turck, PharmD, BCPS, BCCCP
Maggie Emerson, DNP, APRN, PMHNP-BC
Optimizing Medical Affairs Approaches with CME Best Practices
MAPSChatsOptimizing Medical Affairs Approaches with CME Best Practices
Matt Birnholz, MD
Karen Roy, MSc
Advancing ATTR-CM Identification: Early Findings from TRACE-AI
Heart MattersAdvancing ATTR-CM Identification: Early Findings from TRACE-AI
Bruno Batinica, MD
Bruno Batinica, MD
CME
Overcoming Challenges in Transthyretin Cardiac Amyloidosis
CME/CEOvercoming Challenges in Transthyretin Cardiac Amyloidosis
Mathew S. Maurer, MD
Jan M. Griffin, MD
Frederick Ruberg, MD
Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Ineligible Patients With Multiple Myeloma
MinuteCE®Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Ineligible Patients With Multiple Myeloma
Saad Z. Usmani, MD, MBA
Navigating Treatment Selection After First-line CDK4/6 Inhibitor Progression
MinuteCE®Navigating Treatment Selection After First-line CDK4/6 Inhibitor Progression
Komal Jhaveri, MD, FACP
Virginia Kaklamani, MD, DSc
- CME/CE In-Person & Virtual Event
Illuminating Patient Selection for PBM in AMD: A Case-Based Discussion
October 10, 2026
New Orleans, Louisiana Antithrombotics and Amyloid Therapy: Balancing Risk
MinuteCE®Antithrombotics and Amyloid Therapy: Balancing Risk
Dani Cabral, MD
David Weisman, MD
Komal Jhaveri, MD, FACP
Virginia Kaklamani, MD, DSc
Industry Feature
What Is on the ‘HERIZON’ in 1L HER2+ Gastroesophageal Adenocarcinoma?
Medical Industry FeatureWhat Is on the ‘HERIZON’ in 1L HER2+ Gastroesophageal Adenocarcinoma?
Jennifer Caudle, DO, FACOFP
Syma Iqbal, MD
Putting Into Practice: ctDNA Monitoring of ESR1 Mutations During 1L HR+/HER2− Advanced Breast Cancer
Innovations In MedicinePutting Into Practice: ctDNA Monitoring of ESR1 Mutations During 1L HR+/HER2− Advanced Breast Cancer
Unraveling PMR Pathophysiology: The Central Role of IL-6
Medical Industry FeatureUnraveling PMR Pathophysiology: The Central Role of IL-6
Charles Turck, PharmD, BCPS, BCCCP
Adam Brown, MD
Megan Sullivan, MD
Taking Action in Friedreich Ataxia From Diagnosis to Treatment
Medical Industry FeatureTaking Action in Friedreich Ataxia From Diagnosis to Treatment
Jennifer Caudle, DO, FACOFP
David Lynch, MD
Laura Bleekrode, MD
Groundbreaking Gene Therapy Restores Natural Hearing for Genetic Deafness
Medical Industry FeatureGroundbreaking Gene Therapy Restores Natural Hearing for Genetic Deafness
Lawrence Lustig, M.D.
Bowel Urgency as a Key Symptom in Crohn’s Disease
Medical Industry FeatureBowel Urgency as a Key Symptom in Crohn’s Disease
Partha Nandi, MD
Amy Stewart, CRNP